| # | Drug | Count |
|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 2 |
| 1 | NILOTINIB | 2 |
| 2 | NIVOLUMAB | 2 |
| 3 | TACROLIMUS | 2 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 5 | TACROLIMUS OINTMENT 0.1% | 2 |
| 6 | APIXABAN | 1 |
| 7 | ATEZOLIZUMAB | 1 |
| 8 | CARBIDOPA AND LEVODOPA | 1 |
| 9 | CLOPIDOGREL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RELACORILANT | 1 | 0.0101 |
| 1 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 2 | NERATINIB | 1 | 0.0004 |
| 3 | RASAGILINE MESYLATE | 1 | 0.0001 |
| 4 | NILOTINIB | 2 | 0.0001 |
| 5 | ATEZOLIZUMAB | 1 | 0.0000 |
| 6 | CARBIDOPA AND LEVODOPA | 1 | 0.0000 |
| 7 | LETROZOLE TABLETS | 1 | 0.0000 |
| 8 | NIVOLUMAB | 2 | 0.0000 |
| 9 | LETROZOLE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 2 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |
| 3 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 6 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |